Synergizing Activity of ImmTOR Tolerogenic Nanoparticles & an IL-2 Mutein to Expand Antigen- Specific Tregs

Time: 2:00 pm
day: Day One | Track B | Morning

Details:

  • Co-administering antigens with ImmTOR nanoparticles encapsulating rapamycin to induce antigen-specific tolerance
  • Using ImmTOR combination with a fungal-derived uricase enzyme in Ph3 clinical trials in for the treatment of chronic refractory gout
  • Combining ImmTOR with an IL-2 mutein and antigen to induce massive expansion of antigen-specific Tregs in vivo

Speakers: